About this trial
The diagnose of symptomatic osteoarthritis in the ankle, mid- and hind foot remains challenging. There is no gold standard for the work-up and various hospitals use different protocols. Current literature shows a promising role for SPECT-CT imaging in ankle, hind- and midfoot OA. In a previous study investigating the role of SPECT-CT in a reproducible group we have observed a change in diagnosis in 53% when SPECT-CT data was added to the data of conventional workup alone. In 26% of patients addition of SPECT-CT data resulted in change of the original treatment plan. To our knowledge no prospective studies are available on this subject for both SPECT-CT and MRI. In our clinic both SPECT-CT and MRI are used in the work-up for patients with ankle, hind- and midfoot pain. Although we experience good result with SPECT-CT, MRI might be able to detect symptomatic OA as well. Moreover MRI provide more information about soft tissue and is less harmful for the patient in comparison to SPECT-CT. The aim of this study is to determine the diagnostic performance of SPECT-CT and MRI when used routinely in patients with symptomatic OA of the ankle, hind- and midfoot.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Suspected symptomatic ankle, hind- or midfoot OA
Informed consent
Age ≥ 18 years
Average NRS ≥4 over the past week.
Disqualifiers
Contraindication for surgery
Contraindication for SPECT-CT or MRI
Contraindication for intra-articular injections
Isolated forefoot pathology
Trial population
Eligible patients subjects will be all patients referred to the Martini Hospital Groningen with suspected OA of the foot and ankle meeting our inclusion criteria. In total 369 patients will be included. A sample of two months showed that 68 new eligible patients were presented at the outpatient clinic with a prevelence of OA in 85%. We assume that at least 50% of the eligible patients are willing to participate in this study, so it is expected that within 24-30 months all patients can be recruited.
Trial design
Cohort
Prospective
Treatments tested in this trial
SPECT/CT
Diagnostic testSPECT/CT of the foot and ankle
MRI
Diagnostic testMRI of the foot and ankle
Treatment groups
Trial outcomes
Primary outcomes
Diagnostic accuracy of SPECT/CT and MRI
Primary objective is to determine overall diagnostic performance (in terms of sensitivity + specificity, positive and negative predictive values, positive and negative likelihood ratios, and diagnostic odds ratio) of SPECT-CT and MRI for diagnosing symptomatic OA in the ankle, hind- and midfoot.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.